Euvipharm Pharmaceutical Joint-Stock Company announced that it will receive funding from Cuu Long Pharmaceutical Joint-Stock Corporation (HOSE:DCL) on January 6, 2017. The transaction was approved by the board of directors of the investor. The company intends to complete the transaction in the first quarter of 2017.